Last updated on December 2018

Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)


Brief description of study

The purpose this study is to evaluate the efficacy, safety, and pharmacokinetics of GDC-0853 compared with placebo in participants with Chronic Spontaneous Urticaria (CSU) refractory to anti-histamines.

Clinical Study Identifier: NCT03137069

Contact Investigators or Research Sites near you

Start Over

Reference study Id Number: GS39684 ...

Integrated Research of Inland
Upland, CA United States
0.84miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.